200 related articles for article (PubMed ID: 31632020)
21. Micelle-templated, poly(lactic-
Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
[TBL] [Abstract][Full Text] [Related]
22. Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.
Markowski A; Jaromin A; Migdał P; Olczak E; Zygmunt A; Zaremba-Czogalla M; Pawlik K; Gubernator J
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628352
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
24. Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells.
Singh D; Mohapatra P; Kumar S; Behera S; Dixit A; Sahoo SK
Toxicol In Vitro; 2022 Mar; 79():105293. PubMed ID: 34883246
[TBL] [Abstract][Full Text] [Related]
25. Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.
Nagini S; Nivetha R; Palrasu M; Mishra R
J Med Chem; 2021 Apr; 64(7):3560-3577. PubMed ID: 33739088
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells.
Tran P; Nguyen TN; Lee Y; Tran PN; Park JS
Korean J Physiol Pharmacol; 2021 Sep; 25(5):479-488. PubMed ID: 34448465
[TBL] [Abstract][Full Text] [Related]
28. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
29. Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis.
Mohapatra P; Madhulika S; Behera S; Singh P; Sa P; Prasad P; Swain RK; Sahoo SK
Mol Ther Nucleic Acids; 2023 Dec; 34():102031. PubMed ID: 37771911
[TBL] [Abstract][Full Text] [Related]
30. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
Samkange T; D'Souza S; Obikeze K; Dube A
J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
[TBL] [Abstract][Full Text] [Related]
31. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Effects of Paclitaxel Loaded Polyethylene Glycol-Polylactic Acid-Glycolic Acid Copolymer Nanoparticles on Pancreatic Cancer in Rats.
Fu Y; Tan L; Meng L; Lei X
J Nanosci Nanotechnol; 2020 Dec; 20(12):7271-7275. PubMed ID: 32711590
[TBL] [Abstract][Full Text] [Related]
33. Degradable porous drug-loaded polymer scaffolds for localized cancer drug delivery and breast cell/tissue growth.
Obayemi JD; Jusu SM; Salifu AA; Ghahremani S; Tadesse M; Uzonwanne VO; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110794. PubMed ID: 32409024
[TBL] [Abstract][Full Text] [Related]
34. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Zheng Y; Yu B; Weecharangsan W; Piao L; Darby M; Mao Y; Koynova R; Yang X; Li H; Xu S; Lee LJ; Sugimoto Y; Brueggemeier RW; Lee RJ
Int J Pharm; 2010 May; 390(2):234-41. PubMed ID: 20156537
[TBL] [Abstract][Full Text] [Related]
35. Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics.
Khan I; Joshi G; Nakhate KT; Ajazuddin ; Kumar R; Gupta U
Pharm Res; 2019 Aug; 36(10):149. PubMed ID: 31420752
[TBL] [Abstract][Full Text] [Related]
36. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
37. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
Elumalai P; Gunadharini DN; Senthilkumar K; Banudevi S; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Toxicol Lett; 2012 Nov; 215(2):131-42. PubMed ID: 23089555
[TBL] [Abstract][Full Text] [Related]
39. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
40. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]